Market Cap 1.24B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 10,016,179
Avg Vol 5,672,108
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 37%
Beta 1.02
Analysts Strong Sell
Price Target $10.14

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Ed_Ng
Ed_Ng May. 21 at 4:56 PM
$ABCL you're welcome 🤗! Time will tell. I never wrong trading this POS!
1 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler May. 21 at 4:53 PM
$ABCL In at 5.11
0 · Reply
NJgolfer
NJgolfer May. 21 at 4:35 PM
$ABCL up 28% since highlighting the volume move. Most of the time, volume proceeds price action.
1 · Reply
Olivia_Strickland
Olivia_Strickland May. 21 at 4:30 PM
$ABCL up 16% on a 0.85x avg vol day, which is the kind of breakout where the room is empty but somebody clearly didn't get the memo. biotech ripping into +65% on the quarter without the usual ADC/oncology headline blast feels off, the tape is moving like there's a reason and the news flow just hasn't caught up. something specific is doing the work here and it's not what's trending on my feed. who else has eyes on this and what are you seeing that I'm not? where the volume showed up: https://tapeboard.com/chart/ABCL?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=abcl-bk-up-vol
0 · Reply
tranq19
tranq19 May. 21 at 4:09 PM
$ABCL phase 2, started in January, given they were measuring at four weeks. Do you really think they don’t already know what the results are gonna look like 
0 · Reply
Ed_Ng
Ed_Ng May. 21 at 4:09 PM
$ABCL add more to short position. Easy money!
4 · Reply
snowPOW
snowPOW May. 21 at 4:08 PM
$ABCL too small of a market cap. To 20B
0 · Reply
Quadruple_Double
Quadruple_Double May. 21 at 4:08 PM
$ABCL will either spike to $6 by EOD or dump back. No in between. Just a prediction.
1 · Reply
snowPOW
snowPOW May. 21 at 4:06 PM
0 · Reply
Mseni
Mseni May. 21 at 4:06 PM
$ABCL any news here other than a short squeeze?
1 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 9 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 9 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 16 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 22 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 22 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 5 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 6 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Ed_Ng
Ed_Ng May. 21 at 4:56 PM
$ABCL you're welcome 🤗! Time will tell. I never wrong trading this POS!
1 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler May. 21 at 4:53 PM
$ABCL In at 5.11
0 · Reply
NJgolfer
NJgolfer May. 21 at 4:35 PM
$ABCL up 28% since highlighting the volume move. Most of the time, volume proceeds price action.
1 · Reply
Olivia_Strickland
Olivia_Strickland May. 21 at 4:30 PM
$ABCL up 16% on a 0.85x avg vol day, which is the kind of breakout where the room is empty but somebody clearly didn't get the memo. biotech ripping into +65% on the quarter without the usual ADC/oncology headline blast feels off, the tape is moving like there's a reason and the news flow just hasn't caught up. something specific is doing the work here and it's not what's trending on my feed. who else has eyes on this and what are you seeing that I'm not? where the volume showed up: https://tapeboard.com/chart/ABCL?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=abcl-bk-up-vol
0 · Reply
tranq19
tranq19 May. 21 at 4:09 PM
$ABCL phase 2, started in January, given they were measuring at four weeks. Do you really think they don’t already know what the results are gonna look like 
0 · Reply
Ed_Ng
Ed_Ng May. 21 at 4:09 PM
$ABCL add more to short position. Easy money!
4 · Reply
snowPOW
snowPOW May. 21 at 4:08 PM
$ABCL too small of a market cap. To 20B
0 · Reply
Quadruple_Double
Quadruple_Double May. 21 at 4:08 PM
$ABCL will either spike to $6 by EOD or dump back. No in between. Just a prediction.
1 · Reply
snowPOW
snowPOW May. 21 at 4:06 PM
0 · Reply
Mseni
Mseni May. 21 at 4:06 PM
$ABCL any news here other than a short squeeze?
1 · Reply
Lolichocho
Lolichocho May. 21 at 4:03 PM
$ABCL 👀 beautiful bounce, still very long here
0 · Reply
PLTRLONGDONG
PLTRLONGDONG May. 21 at 4:00 PM
$ABCL you keep saying rumors… spill the beans if you have anything
0 · Reply
CoffeeInTheSnow
CoffeeInTheSnow May. 21 at 3:59 PM
$ABCL we found cure???
0 · Reply
Vargduden
Vargduden May. 21 at 3:52 PM
$ABCL anyone here for the long run like me? Not trimming before 50$
0 · Reply
inflect1on
inflect1on May. 21 at 3:48 PM
$ABCL 4.05 HL and then strong reaction. Those sidelined should keep a close eye
0 · Reply
inflect1on
inflect1on May. 21 at 3:45 PM
$ABCL gap closed. Hmmm
2 · Reply
JennyRowes
JennyRowes May. 21 at 3:15 PM
$ABCL what is going on here??
2 · Reply
Stocktradesmoon
Stocktradesmoon May. 21 at 3:14 PM
$ABCL The rumors are true some people are about to get wrecked
1 · Reply
ispy
ispy May. 21 at 3:13 PM
$ABCL So let's pick out paint colors for the new 911...
0 · Reply
Plutten1973
Plutten1973 May. 21 at 2:54 PM
1 · Reply
Art_BunyaaHa
Art_BunyaaHa May. 21 at 2:49 PM
$ABCL 🔥 🩳
0 · Reply
DeMampCamp
DeMampCamp May. 21 at 2:49 PM
1 · Reply